Use of Naltrexone in a Clinical Setting

Launched by NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM (NIAAA) · Nov 2, 1999

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Meets criteria for alcohol dependence (within the past 3 months).
• • Meets criteria for another substance use disorder (except narcotic dependence) but must identify alcohol as the primary substance of abuse.
• • Must be able to provide an informed consent.
• • Consent to random assignment and be willing to commit to possible medication treatment and research follow-up.
• • Must be eligible for treatment at the Dorchester Alcohol and Drug Commission.
• Exclusion Criteria:
• • Meets criteria for opiate dependence.
• • Clinically significant medical problems such as collagen-vascular disease, cardiovascular, renal, gastrointestinal or endocrine problem that would impair participation or limit medication ingestion.
• • Hepatocellular disease.
• • Women who are pregnant, nursing, or not practicing an effective means of birth control.
• • Currently being prescribed naltrexone.
• • Known sensitivity or allergy to naltrexone.